Horizon Kinetics Inflation Beneficiaries ETF (NYSEARCA:INFL – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $38.24 and last traded at $38.24, with a volume of 5921 shares trading hands. The stock had previously closed at $38.03.
Horizon Kinetics Inflation Beneficiaries ETF Price Performance
The stock has a market capitalization of $751.27 million, a price-to-earnings ratio of 14.64 and a beta of 0.69. The firm’s fifty day moving average is $36.04 and its 200-day moving average is $33.96.
Institutional Investors Weigh In On Horizon Kinetics Inflation Beneficiaries ETF
Institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp increased its holdings in Horizon Kinetics Inflation Beneficiaries ETF by 23.5% in the second quarter. Bank of New York Mellon Corp now owns 223,372 shares of the company’s stock valued at $7,300,000 after buying an additional 42,538 shares during the last quarter. Hilltop National Bank raised its position in shares of Horizon Kinetics Inflation Beneficiaries ETF by 12.6% during the 2nd quarter. Hilltop National Bank now owns 96,217 shares of the company’s stock valued at $3,144,000 after acquiring an additional 10,802 shares in the last quarter. Finally, Lowe Wealth Advisors LLC lifted its stake in Horizon Kinetics Inflation Beneficiaries ETF by 4.1% during the second quarter. Lowe Wealth Advisors LLC now owns 222,824 shares of the company’s stock worth $7,282,000 after purchasing an additional 8,799 shares during the last quarter.
About Horizon Kinetics Inflation Beneficiaries ETF
The Horizon Kinetics Inflation Beneficiaries ETF (INFL) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively-managed fund seeking long-term capital growth in inflation-adjusted terms from companies expected to benefit, directly or indirectly, from inflation. INFL was launched on Jan 11, 2021 and is managed by Horizon Kinetics.
Read More
- Five stocks we like better than Horizon Kinetics Inflation Beneficiaries ETF
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What are earnings reports?
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Horizon Kinetics Inflation Beneficiaries ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Kinetics Inflation Beneficiaries ETF and related companies with MarketBeat.com's FREE daily email newsletter.
